Biolectron (US) enters tissue attachment market
This article was originally published in Clinica
Executive Summary
Biolectron (US) has acquired manufacturing and marketing rights to Romano Surgical Instruments' surgical curved drill technology. Under the exclusive worldwide agreement, inventor Jack Romano will work with Biolectron on development of the product line. Terms of the agreement have not been disclosed. The drill system has been proven effective in Bankart shoulder surgery, allowing quicker soft tissue attachment to be performed with greater ease and precision, says Biolectron.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.